Allied Journal of Medical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Mini Review - Allied Journal of Medical Research (2023) Volume 7, Issue 6

Immunization in the Face of Antimicrobial Resistance

Dun Keng *

Department of Entomology, Northwest A&F University, Yangling, China

*Corresponding Author:
Dun Keng
Department of Entomology, Northwest A&F University, Yangling, China
Northwest A&F University, Yangling, China

Received: 28-Oct-2023, Manuscript No. AAAJMR -23-119517; Editor assigned: 31-Oct-2023, PreQC No. AAAJMR -23-119517 (PQ); Reviewed: 14-Nov-2023, QC No. AAAJMR -23-119517; Revised:20-Nov-2023, Manuscript No. AAAJMR-23-119517 (R); Published: 27-Nov-2023, DOI:10.35841/ aaajmr-7.6.202

Citation: Citation: Keng D. Immunization in the face of antimicrobial resistance. Allied J Med Res. 2023;7(6):202

Visit for more related articles at Allied Journal of Medical Research



Antimicrobial resistance (AMR) looms as an increasingly formidable global health challenge, threatening our ability to combat infectious diseases effectively. In the battle against this growing menace, immunization emerges as a crucial ally, working in tandem with antibiotics and other measures to safeguard public health. [1]

This article explores the dynamic interplay between immunization and AMR, emphasizing the pivotal role of vaccines in preserving the efficacy of existing antimicrobials, reducing the burden of infections, and ultimately saving lives. [2].

Antimicrobial resistance is an urgent and multifaceted crisis that transcends national borders. It occurs when microorganisms, including bacteria, viruses, and fungi, adapt to the drugs that were once their nemeses, rendering antibiotics and antiviral medications less effective. The implications of AMR are profound: common bacterial infections become increasingly difficult to treat, leading to higher rates of morbidity and mortality. [3].

Healthcare systems worldwide are strained as they grapple with the repercussions of resistant pathogens. Without concerted and immediate action, we risk returning to an era where seemingly minor injuries and routine infections pose life-threatening risks. [4].

Immunization as a first line of defense

Vaccination stands as a formidable pillar in the fight against AMR. Its significance lies in its capacity to prevent infections at the outset, thereby reducing the demand for antibiotics and mitigating the selective pressures that drive the emergence of antimicrobial resistance. In essence, by averting infections, vaccines act as sentinels that safeguard the effectiveness of antibiotics, preserving these crucial medications for when they are most needed. This approach not only lessens the burden on healthcare systems but also contributes to the sustainability of antimicrobial therapies [5].

Vaccination's role in reducing infections and antibiotic use

Vaccines have demonstrated their effectiveness in reducing the incidence of infections caused by bacteria and viruses, thus diminishing the need for antibiotics. Diseases such as pneumococcal pneumonia, meningitis, and Haemophilus influenzae type b (Hib) infections have seen a significant decline in incidence thanks to vaccination programs. When infections are prevented, antibiotics are less frequently prescribed, reducing the opportunities for resistance to develop [6].

Combating antimicrobial resistance through preventive vaccines

Innovative vaccines have the potential to target specific pathogens and prevent the spread of AMR. For example, vaccines against Streptococcus pneumoniae and Neisseria meningitidis are instrumental in reducing the incidence of antibiotic-resistant strains. Additionally, vaccination against seasonal influenza helps limit the misuse of antibiotics for viral infections that are often inaccurately treated with antimicrobial agents [7].

Education and public awareness campaigns are essential components in the battle against AMR. Communities must understand the importance of vaccines in preventing infections and slowing the rise of resistance. Efforts to increase vaccination rates, particularly for routine childhood immunizations, are vital [8].

The synergy between immunization and the fight against antimicrobial resistance cannot be overstated. Vaccines not only prevent infections but also reduce the demand for antibiotics, thus curbing the development and spread of resistant pathogens. By embracing immunization as a first line of defence [9].

we strengthen our collective ability to combat AMR, safeguard the efficacy of antibiotics, and secure a healthier future for generations to come. Public awareness and commitment to vaccination programs are crucial, as they form the foundation of this multifaceted approach to global health [10].


  1. Baker SJ, Payne DJ, Rappuoli R, et al. Technologies to address antimicrobial resistance. Proc Natl Acad Sci. 2018 Dec 18;115(51):12887-95.
  2. Indexed at, Google Scholar, Cross Ref

  3. Mantel C, Cherian T. New immunization strategies: adapting to global challenges. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz. 2020 Jan;63(1):25-31.
  4. Indexed at, Google Scholar, Cross Ref

  5. Harbarth S, Balkhy HH, Goossens H, et al. World Healthcare-Associated Infections Resistance Forum participants. Antimicrobial resistance: One world, one fight!.
  6. Google Scholar

  7. Awasthi R, Rakholia V, Agrawal S, et al. Estimating the impact of health systems factors on antimicrobial resistance in priority pathogens. J Glob Antimicrob. Resist. 2022;30:133-42.
  8. Indexed at, Google Scholar, Cross Ref

  9. Kamata K, Tokuda Y, Gu Y, et al. Public knowledge and perception about antimicrobials and antimicrobial resistance in Japan: A national questionnaire survey in 2017. PloS one. 2018 Nov 5;13(11):e0207017.
  10. Indexed at, Google Scholar, Cross Ref

  11. Mallakpour S, Azadi E, Hussain CM. Protection, disinfection, and immunization for healthcare during the COVID-19 pandemic: Role of natural and synthetic macromolecules. Sci. Total Environ. 2021;776:145989.
  12. Google Scholar

  13. Shin S, Desai SN, Sah BK, et al. Oral vaccines against cholera. Clinical infectious diseases. 2011;52(11):1343-9.
  14. Google Scholar

  15. Piot P, Larson HJ, O’Brien KL, et al. Immunization: Vital progress, unfinished agenda. Nature. 2019;575(7781):119-29.
  16. Indexed at, Google Scholar, Cross Ref

  17. Sheikh BA, Bhat BA, Mir MA. Antimicrobial resistance: New insights and therapeutic implications. Appl. Microbiol. Biotechnol. 2022;106(19-20):6427-40.

Indexed at, Google Scholar, Cross Ref

Indexed at, Google Scholar, Cross Ref

Get the App